HomeLPTX • NASDAQ
add
Leap Therapeutics Inc
Previous close
$0.29
Day range
$0.28 - $0.31
Year range
$0.22 - $4.79
Market cap
12.16M USD
Avg Volume
1.72M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 12.35M | -41.17% |
Net income | -16.64M | 18.26% |
Net profit margin | — | — |
Earnings per share | -0.40 | 23.08% |
EBITDA | -12.35M | 41.18% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 18.13M | -76.90% |
Total assets | 20.04M | -75.39% |
Total liabilities | 14.32M | -8.40% |
Total equity | 5.72M | — |
Shares outstanding | 41.44M | — |
Price to book | 2.04 | — |
Return on assets | -112.46% | — |
Return on capital | -230.90% | — |
Cash Flow
Net change in cash
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Net income | -16.64M | 18.26% |
Cash from operations | -14.49M | -5.96% |
Cash from investing | — | — |
Cash from financing | -119.00K | -100.32% |
Net change in cash | -14.58M | -161.90% |
Free cash flow | -5.71M | 11.48% |
About
Founded
2011
Website
Employees
26